Previous 10 | Next 10 |
IceCure Medical's ProSense® Cryoablation System Submitted for Regulatory Approval in Brazil PR Newswire Regulatory filing submitted by KTRFIOS, IceCure's distributor in Brazil Filing includes breast and other cancers, benign tumors, palliative ...
IceCure Medical Ltd. (ICCM) Q1 2022 Earnings Conference Call May 18, 2022 8:30 AM ET Company Participants Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Officer and Chief Operating Officer Richard Fine - Investigator of ICE3 Clinical Trial Conference Call Participants...
IceCure Medical press release (NASDAQ:ICCM): Q1 GAAP EPS of -$0.12. Revenue of $0.75M (-47.6% Y/Y). As of March 31, 2022, the Company had cash and cash equivalents of approximately $22.4 million, compared with approximately $25.6 million as of December 31, 2021. For further details see: ...
IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights PR Newswire Conference call scheduled for 8:30 am ET today hosted by management with guest Dr. Richard Fine Increased commercial activity in the U.S. and glo...
IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022 PR Newswire CAESAREA, Israel , May 11, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive c...
IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoa...
Clarus Therapeutics (CRXT) +18%. AlloVir (ALVR) +18% on FDA regenerative medicine tag for posoleucel to prevent 6 viruses in cell transplant patients. Westwater Resources (WWR) +15% and Alabama Graphite Products break ground on Kellyton processing plant. IceCure Medical (...
Gainers Bakkt Holdings (NYSE:BKKT) +30%. Kaival Brands Innovations Group (NASDAQ:KAVL) +29%. CF Acquisition (NASDAQ:CFVIU) +21%. CF Acquisition (NASDAQ:CFVI) +19%. Origin Agritech (NASDAQ:SEED) +20%. Phunware (NASDAQ:PHUN) +19%. IceCure Medical (NASDAQ:ICCM) +17%. Peloton Interactive (NASDAQ:...
Gainers: IceCure Medical (NASDAQ:ICCM) +16%. Atossa Therapeutics (NASDAQ:ATOS) +15%. G Medical Innovations (NASDAQ:GMVD) +11%. Exscientia (NASDAQ:EXAI) +10%. Immix Biopharma (NASDAQ:IMMX) +10%. Losers: Dermata Therapeutics (NASDAQ:DRMA) -...
Peloton Interactive PTON +32% Amazon buying Peloton would give it several benefits, including Prime boost: Truist. IceCure Medical (NASDAQ:ICCM) +17%. Origin Agritech (NASDAQ:SEED) +15% issues 2022 guidance of 300% revenue growth. Spirit Airlines SAVE +11% on Q4 results. H...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...